Identification of Age-Associated Transcriptomic Changes Linked to Immunotherapy Response in Primary Melanoma

Melanoma is a lethal form of skin cancer. Immunotherapeutic agents such as anti-PD-1 (pembrolizumab and nivolumab) and anti-CTLA-4 (ipilimumab) have revolutionized melanoma treatment; however, drug resistance is rapidly acquired. Several studies have reported an increase in melanoma rates in older p...

Full description

Bibliographic Details
Main Authors: Nehal Farid El-Helbawy, Ahmed Ezat El Zowalaty
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Current Issues in Molecular Biology
Subjects:
Online Access:https://www.mdpi.com/1467-3045/44/9/282
_version_ 1827662277450399744
author Nehal Farid El-Helbawy
Ahmed Ezat El Zowalaty
author_facet Nehal Farid El-Helbawy
Ahmed Ezat El Zowalaty
author_sort Nehal Farid El-Helbawy
collection DOAJ
description Melanoma is a lethal form of skin cancer. Immunotherapeutic agents such as anti-PD-1 (pembrolizumab and nivolumab) and anti-CTLA-4 (ipilimumab) have revolutionized melanoma treatment; however, drug resistance is rapidly acquired. Several studies have reported an increase in melanoma rates in older patients. Thus, the impact of ageing on transcriptional profiles of melanoma and response to immunotherapy is essential to understand. In this study, the bioinformatic analysis of RNA seq data of old and young melanoma patients receiving immunotherapy identifies the significant upregulation of extra-cellular matrix and cellular adhesion genes in young cohorts, while genes involved in cell proliferation, inflammation, non-canonical Wnt signaling and tyrosine kinase receptor ROR2 are significantly upregulated in the old cohort. Several Treg signature genes as well as transcription factors that are associated with dysfunctional T cell tumor infiltration are differentially expressed. The differential expression of several genes involved in oxidative phosphorylation, glycolysis and glutamine metabolism is also observed. Taken together, this study provides novel findings on the impact of ageing on transcriptional changes in melanoma, and novel therapeutic targets for future studies.
first_indexed 2024-03-10T00:22:50Z
format Article
id doaj.art-752ae76ef841462e991f96c4c36ccc7b
institution Directory Open Access Journal
issn 1467-3037
1467-3045
language English
last_indexed 2024-03-10T00:22:50Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series Current Issues in Molecular Biology
spelling doaj.art-752ae76ef841462e991f96c4c36ccc7b2023-11-23T15:39:17ZengMDPI AGCurrent Issues in Molecular Biology1467-30371467-30452022-09-014494118413110.3390/cimb44090282Identification of Age-Associated Transcriptomic Changes Linked to Immunotherapy Response in Primary MelanomaNehal Farid El-Helbawy0Ahmed Ezat El Zowalaty1Department of Anatomy and Embryology, Faculty of Medicine, Tanta University, Tanta 31111, EgyptSahlgrenska Center for Cancer Research, Department of Surgery, Institute of Clinical Sciences, University of Gothenburg, 40530 Gothenburg, SwedenMelanoma is a lethal form of skin cancer. Immunotherapeutic agents such as anti-PD-1 (pembrolizumab and nivolumab) and anti-CTLA-4 (ipilimumab) have revolutionized melanoma treatment; however, drug resistance is rapidly acquired. Several studies have reported an increase in melanoma rates in older patients. Thus, the impact of ageing on transcriptional profiles of melanoma and response to immunotherapy is essential to understand. In this study, the bioinformatic analysis of RNA seq data of old and young melanoma patients receiving immunotherapy identifies the significant upregulation of extra-cellular matrix and cellular adhesion genes in young cohorts, while genes involved in cell proliferation, inflammation, non-canonical Wnt signaling and tyrosine kinase receptor ROR2 are significantly upregulated in the old cohort. Several Treg signature genes as well as transcription factors that are associated with dysfunctional T cell tumor infiltration are differentially expressed. The differential expression of several genes involved in oxidative phosphorylation, glycolysis and glutamine metabolism is also observed. Taken together, this study provides novel findings on the impact of ageing on transcriptional changes in melanoma, and novel therapeutic targets for future studies.https://www.mdpi.com/1467-3045/44/9/282melanomaageingRNA-seqtranscriptional profilesgene expressionimmunotherapy
spellingShingle Nehal Farid El-Helbawy
Ahmed Ezat El Zowalaty
Identification of Age-Associated Transcriptomic Changes Linked to Immunotherapy Response in Primary Melanoma
Current Issues in Molecular Biology
melanoma
ageing
RNA-seq
transcriptional profiles
gene expression
immunotherapy
title Identification of Age-Associated Transcriptomic Changes Linked to Immunotherapy Response in Primary Melanoma
title_full Identification of Age-Associated Transcriptomic Changes Linked to Immunotherapy Response in Primary Melanoma
title_fullStr Identification of Age-Associated Transcriptomic Changes Linked to Immunotherapy Response in Primary Melanoma
title_full_unstemmed Identification of Age-Associated Transcriptomic Changes Linked to Immunotherapy Response in Primary Melanoma
title_short Identification of Age-Associated Transcriptomic Changes Linked to Immunotherapy Response in Primary Melanoma
title_sort identification of age associated transcriptomic changes linked to immunotherapy response in primary melanoma
topic melanoma
ageing
RNA-seq
transcriptional profiles
gene expression
immunotherapy
url https://www.mdpi.com/1467-3045/44/9/282
work_keys_str_mv AT nehalfaridelhelbawy identificationofageassociatedtranscriptomicchangeslinkedtoimmunotherapyresponseinprimarymelanoma
AT ahmedezatelzowalaty identificationofageassociatedtranscriptomicchangeslinkedtoimmunotherapyresponseinprimarymelanoma